Using lipidomics analysis to identify therapeutic targets in cancer and infection

1:00pm - 2:00pm / Monday 4th February 2019 / Venue: Lecture Theatre 1 Life Sciences Building
Type: Seminar / Category: Research / Series: GSTT Seminar Series
  • Suitable for: Staff and students with an interest in Genomes, Systems and Therapeutic Targeting
  • Admission: Free event
  • Add this event to my calendar
    (?)

    When you click on "Add this event to my calendar" your browser will download an ics file.

    Microsoft Outlook: Download the file, then you may be able to click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open, then Import. Select "Import an iCalendar (.ic or vCalendar file (.vcs)" then click on Next. Find the .ics file and click on OK.

    Google Calendar: download the file, then go into your calendar. On the right where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.

    Apple Calendar: download the file, then you can either drag it to Calendar or import the file by going to File > Import > Import and choosing the .ics file.

Speaker: Michael Wakelam (Babraham Institute)

Advances in mass spectrometry have facilitated the development of methodologies that allow the determination of cellular and tissue lipidomes. Theoretically mammalian cells contain many thousands of individual lipid molecular species and whilst it is unlikely that all are present in a single cell, lipidomics experiments have demonstrated the presence of more than a thousand species. The integrated regulation of changes in lipid species controls cellular functions, including signalling and metabolism, highlighting the need for bioinformatics analysis to fully interpret lipidomics data. Using two experimental systems: human colorectal tumour tissue and rhinovirus-infected human bronchial epithelial cells, together with pathway analysis of lipid metabolising enzymes coupled to network optimising Prize-collecting Steiner tree problem methodology, we have identified key enzymatic changes with potential to be both biomarkers and therapeutic targets for treating cancer and infections.